SCHEMBL21757030

SCHEMBL21757030

CC(=O)N1CCC2(CCC(C)CC2)C1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 1/20 0.43
OPRL1 P41146 1/20 0.43
CYP2C19 P33261 4/20 0.41
ALDH1A1 P00352 3/20 0.41
MAPK1 P28482 1/20 0.41
CYP3A4 P08684 6/20 0.41
HIF1A Q16665 2/20 0.41
CYP11B1 P15538 1/20 0.41
CYP11B2 P19099 1/20 0.41
CYP2D6 P10635 6/20 0.40
HSD17B10 Q99714 3/20 0.40
CYP2C9 P11712 3/20 0.40
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
USP2 O75604 3/20 0.39
CYP1A2 P05177 3/20 0.38
TSHR P16473 2/20 0.38
HPGD P15428 1/20 0.38
ALOX15 P16050 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23240355 0.86 SMN1; SMN2 (0.45) CYP2C19ALDH1A1MAPK1CYP3A4HIF1A
SCHEMBL5986519 0.84 OPRM1 (0.54) OPRM1OPRL1CYP2C19ALDH1A1MAPK1
SCHEMBL21756986 0.84 GRM5 (0.37) OPRM1OPRL1CYP2C19ALDH1A1CYP3A4
SCHEMBL20144252 0.83 CYP2C19 (0.42) OPRM1OPRL1CYP2C19ALDH1A1MAPK1
SCHEMBL16852620 0.80 CYP3A4 (0.53) OPRM1OPRL1CYP2C19ALDH1A1MAPK1
SCHEMBL23707472 0.79 SMN1; SMN2 (0.42) CYP2C19ALDH1A1MAPK1CYP3A4HIF1A
SCHEMBL6233534 0.79 CYP3A4 (0.51) OPRM1OPRL1CYP2C19ALDH1A1CYP3A4
SCHEMBL23763347 0.79 CYP1A2 (0.52) OPRM1OPRL1CYP2C19ALDH1A1MAPK1
SCHEMBL21757045 0.77 EPHX2 (0.45) OPRM1OPRL1CYP2C19CYP2C9GRM5
SCHEMBL21757048 0.76 JAK1 (0.45) OPRM1OPRL1ALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022161205-A1 ORAL PREPARATION CONTAINING JAK INHIBITOR OR SALT THEREOF OR CRYSTAL FORM THEREOF, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF 珠海联邦制药股份有限公司 2022-08-04 WO disclosed
WO-2021159372-A1 USE OF JAK INHIBITORS IN PREPARATION OF DRUGS FOR TREATING JAK KINASE-RELATED DISEASES 珠海联邦制药股份有限公司 2021-08-19 WO disclosed
EP-3842431-A1 [1,2,4]TRIAZOLO[1,5-A]PYRIDINE COMPOUND AS JAK INHIBITOR AND APPLICATION THEREOF Zhuhai United Laboratories Co., Ltd (CN) 2021-06-30 EP disclosed
WO-2020038457-A1 [1,2,4]TRIAZOLO[1,5-A]PYRIDINE COMPOUND AS JAK INHIBITOR AND APPLICATION THEREOF 珠海联邦制药股份有限公司 2020-02-27 WO disclosed